Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Clinician,Cannabidiol,"Dravet Syndrome, adjunctive therapy",Cannabidiol (Epidyolex oral solution),Options for investment,Community and Hospital,Nervous System
